Medicare Enrolled
Dr. Francisco Belette, M.D.
Hematology & Oncology · Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Belette from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Belette?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Belette
Dr. Francisco Belette is a hematology & oncology specialist in Miami, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Belette performed 69 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Belette received a total of $28,677 from 97 pharmaceutical and/or device companies across 1398 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Belette is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ 69 Medicare services
$28,677 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 61820 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗69
Medicare services
Bottom 3% in FL for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $102 | $257 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $72 | $167 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$28,677
Total received (2018-2024)
Avg $4,097/year across 7 years
Top 20% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
97
Companies
1,398
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,236
2023
$5,069
2022
$4,382
2021
$1,827
2020
$2,716
2019
$3,887
2018
$3,560
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$1,062
Novartis Pharmaceuticals Corporation
$922
PFIZER INC.
$562
Celgene Corporation
$539
Merck Sharp & Dohme LLC
$364
Janssen Biotech, Inc.
$309
Lilly USA, LLC
$291
E.R. Squibb & Sons, L.L.C.
$219
Daiichi Sankyo Inc.
$215
Astellas Pharma US Inc
$205
ABBVIE INC.
$179
Incyte Corporation
$162
PharmaEssentia USA Corporation
$156
Eisai Inc.
$132
Sumitomo Pharma America, Inc.
$129
SOBI, INC
$127
BeiGene USA, Inc.
$118
GENZYME CORPORATION
$111
Verity Pharmaceuticals Inc.
$107
Karyopharm Therapeutics Inc.
$100
Bayer Healthcare Pharmaceuticals Inc.
$98
Rigel Pharmaceuticals, Inc.
$92
EMD Serono, Inc.
$92
Tempus AI, Inc
$90
SUN PHARMACEUTICAL INDUSTRIES INC.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$79
SpringWorks Therapeutics, Inc.
$65
Blueprint Medicines Corporation
$63
Stemline Therapeutics Inc.
$63
Fennec Pharmaceuticals, Inc.
$62
GlaxoSmithKline, LLC.
$58
Regeneron Healthcare Solutions, Inc.
$54
Ipsen Biopharmaceuticals, Inc
$49
Mirati Therapeutics, Inc.
$49
Agios Pharmaceuticals, Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
ARRAY BIOPHARMA INC
$27
Novocure Inc.
$26
Myriad Genetic Laboratories, Inc.
$25
Exelixis Inc.
$22
pharmaand GmbH
$22
Cumberland Pharmaceuticals, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$16
Top 3 companies account for 35.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,392
Novartis Pharmaceuticals Corporation
$2,821
Janssen Biotech, Inc.
$2,692
Celgene Corporation
$2,258
PFIZER INC.
$1,707
Merck Sharp & Dohme Corporation
$1,055
Incyte Corporation
$1,015
E.R. Squibb & Sons, L.L.C.
$958
Astellas Pharma US Inc
$912
Merck Sharp & Dohme LLC
$833
EMD Serono, Inc.
$726
Rigel Pharmaceuticals, Inc.
$578
Eisai Inc.
$480
Genentech USA, Inc.
$442
Lilly USA, LLC
$395
Amgen Inc.
$366
Clovis Oncology, Inc.
$319
GENZYME CORPORATION
$274
ABBVIE INC.
$262
Sumitomo Pharma America, Inc.
$256
BeiGene USA, Inc.
$249
Exelixis Inc.
$248
Daiichi Sankyo Inc.
$247
Bayer Healthcare Pharmaceuticals Inc.
$237
AbbVie Inc.
$228
Taiho Oncology, Inc.
$218
Stemline Therapeutics Inc.
$210
Seagen Inc.
$195
SOBI, INC
$192
Kite Pharma, Inc.
$191
Gilead Sciences, Inc.
$190
Verity Pharmaceuticals Inc.
$190
Takeda Pharmaceuticals U.S.A., Inc.
$188
MorphoSys, US Inc.
$187
Boehringer Ingelheim Pharmaceuticals, Inc.
$186
PharmaEssentia USA Corporation
$178
Kyowa Kirin, Inc.
$175
Bayer HealthCare Pharmaceuticals Inc.
$166
Regeneron Healthcare Solutions, Inc.
$162
Karyopharm Therapeutics Inc.
$159
GlaxoSmithKline, LLC.
$144
Sun Pharmaceutical Industries Inc.
$137
EISAI INC.
$119
AngioDynamics, Inc.
$119
MEDIVATION FIELD SOLUTIONS LLC
$113
Janssen Pharmaceuticals, Inc
$109
ADC Therapeutics America, Inc.
$101
JAZZ PHARMACEUTICALS INC.
$100
Mirati Therapeutics, Inc.
$96
Cumberland Pharmaceuticals, Inc.
$95
Tempus AI, Inc
$90
Ipsen Biopharmaceuticals, Inc
$79
SUN PHARMACEUTICAL INDUSTRIES INC.
$79
AbbVie, Inc.
$78
Myovant Sciences Inc.
$74
Myriad Genetic Laboratories, Inc.
$72
Epizyme, Inc.,
$69
Agios Pharmaceuticals, Inc.
$67
SpringWorks Therapeutics, Inc.
$65
Blueprint Medicines Corporation
$63
Fennec Pharmaceuticals, Inc.
$62
Teva Pharmaceuticals USA, Inc.
$59
Pharmacyclics LLC, An AbbVie Company
$57
ARRAY BIOPHARMA INC
$44
Puma Biotechnology, Inc.
$40
TESARO, Inc.
$39
Deciphera Pharmaceuticals Inc.
$39
TOLMAR Pharmaceuticals, Inc.
$38
Dova Pharmaceuticals
$38
Emmaus Medical, Inc.
$35
Alexion Pharmaceuticals, Inc.
$34
CTI BioPharma Corp.
$33
Advanced Accelerator Applications
$33
Janssen Scientific Affairs, LLC
$32
Tolmar, Inc.
$29
Aadi Bioscience, Inc.
$29
Helsinn Therapeutics (U.S.), Inc.
$27
Coherus Biosciences Inc.
$27
TAIHO ONCOLOGY, INC.
$27
Novocure Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$24
Epizyme, Inc.
$24
G1 Therapeutics, Inc.
$24
Pharmacosmos Therapeutics Inc.
$23
Intuitive Surgical, Inc.
$22
pharmaand GmbH
$22
Shire North American Group Inc
$21
Array BioPharma Inc.
$20
Seattle Genetics, Inc.
$19
Foundation Medicine, Inc.
$18
Verastem, Inc.
$18
NOVARTIS PHARMACEUTICALS CORPORATION
$17
RECORDATI_RARE_DISEASES_INC.
$16
Organon LLC
$16
Global Blood Therapeutics, Inc.
$16
Amneal Pharmaceuticals LLC
$15
Apellis Pharmaceuticals, Inc.
$13
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BALVERSA · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CHANTIX · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Erleada · FARESTON · FASLODEX · FOUNDATIONONE · Fyarro · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Imbruvica · Inrebic · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ODOMZO (sonidegib) capsules · OGSIVEO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TUKYSA · Tavalisse · Tazverik · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
133
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Belette is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Belette experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Belette performed 47 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Belette receive payments from pharmaceutical companies?
Yes. Dr. Belette received a total of $28,677 from 97 companies across 1,398 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Belette's costs compare to other hematology & oncology specialists in Miami?
Dr. Belette's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Belette) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Miami
Browse hematology & oncology specialists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology